Rate of Inactivation of Isoniazid in South Indian

Patients with Pulmonary Tuberculosis 

2. Clinical Implications in the Treatment of Pulmonary

Tuberculosis with Isoniazid either Alone or in Combination with PAS by Selkon, J B et al.
Rate of Inactivation of Isoniazid in South Indian
Patients with Pulmonary Tuberculosis *
2. Clinical Implications in the Treatment of Pulmonary
Tuberculosis with Isoniazid either Alone or in Combination with PAS
J. B. SELKON, WALLACE FOX, P. R. J. GANGADHARAM, K. RAMACHANDRAN,
C. V. RAMAKRISHNAN & S. VELU
A series of studies on the rate of inactivation of isoniazid in Indian patients with pul-
monary tuberculosis undergoing domiciliary chemotherapy with isoniazid, alone or in com-
bination with p-aminosalicylic acid, has recently been undertaken by the Tuberculosis
Chemotherapy Centre, Madras.In the first study, the serum isoniazid levels of the patients
were determined four-and-a-half hours after intramuscular administration of a andard
dose of 3 mg/kg body-weight of isoniazid and, according to whether the serum level was
0.58 µg/ml or above, or less than 0.58 µg/ml, the patient was classified as a slow or as a
rapid inactivator. The present paper describes the second of th se studies, in which the
response to treatment of the slow and the rapid inactivators was compared.The sults of
this investigation suggested that there might be an association between response to treatment
and rate of inactivation of isoniazid, since the slow inactivators were more often culture-
negative during treatment and showed a higher proportion of individuals with bacterio-
logically quiescent disease at I2 months and a lower proportion with radiographic deteriora-
tion at six months than the rapid inactivators, while the slow inactivators who deteriorated
radiographically or clinically to an extent warranting a change of tre tm nt during the two
years did so later than the corresponding rapid inactivators. There was slight evidence that
the slow and the rapid inactivators differed in the speed of conv rsion to bacteriological
negativity of those patients whose disease was bacteriologically quiescent at 12 months, but
no evidence that they differed in the degree of positivity of sputum specimens that were
positive on culture at six, nine or 12 months, or in the frequency with which the patients
showed moderate or greater radiographic improvement at six months.
INTRODUCTION’ tied as slow or rapid inactivators of isoniazid
A previous report from the Tuberculosis Chemo-
therapy Centre, Madras, presented the results of a
 controlled comparison for a period of 12 months of
three different regimens of isoniazid alone with a
regimen of isoniazid plus p-aminosalicylic acid (PAS)
in the domiciliary treatment of pulmonary tuber-
culosis (Tuberculosis Chemotherapy Centre, 1960).
The patients in this chemotherapy study were classi-
* From the Tuberculosis Chemotherapy Centre, Madras,
India. The Centre is under the joint auspices of the Indian
Council of Medical Research, the Madras State Government,
the World Health Organization and the Medical Research
Council of Great Britain.
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according to the serum concentration of isoniazid
four-and-a-half hours after an intramuscular in-
jection of 3 mg/kg body-weight of isoniazid (Ganga-
dharam et al.,1961 1). Devadatta et al. (1960)
have reported elsewhere that isoniazid-induced
peripheral neuritis was. encountered in 20 of the
341 patients admitted to the study, and that 18 of
these 20 patients were slow inactivators of isoniazid.
The analyses reported here were undertaken to
discover whether an association existed between the
rate of inactivation of isoniazid and the response to
treatment with isoniazid alone or in combination
–  779  –
1 See article on page 765.
780 J. B. SELKON
with PAS. The relationship between the rate of
inactivation of isoniazid and the degree of resistance
to isoniazid, the catalase activity and the virulence
in the guinea-pig of cultures isolated from these
patients during treatment will be reported later.
MATERIALS AND METHODS
Patients
In all, 341 patients with pulmonary tuberculosis
were admitted to the controlled chemotherapy
study. They were allocated at random to treatment
with one of the following regimens for 12 months :
PH (96 patients). Isoniazid 3.9-5.5 mg/kg body-
weight plus PAS (sodium) 0.2-0.3 g/kg daily, divided
into two doses, by mouth–i.e., 200 mg of isoniazid
plus 10 g of PAS (sodium) a day for a patient
weighing 100 lb. (45.4 kg).
HZ-1 (75 patients). I oniazid alone, 7.8-9.6 mg/kg
daily, in one dose by mouth–i.e., 400 mg of iso-
niazid a day for a patient weighing 100 lb.
HZ-2 (75 patients). I oniazid alone, 7.8-9.6 mg/kg
daily, divided into two doses, by mouth–i.e., 400
mg of isoniazid a day for a patient weighing 100 lb.
H (95 patients). Isoniazid alone, 3.9-5.5 mg/kg
daily, divided into two doses, by mouth–i.e., 200
mg of isoniazid a day for a patient weighing 100 lb.
At the end of 12 months’ treatment patients whose
disease was classified as bacteriologically quiescent
or of doubtful status (see page 785) were allocated
at random to treatment with calcium gluconate 0.5 g
daily or isoniazid in a dosage of approximately
4.5 mg/kg daily for a further 12 months (Velu et al.,
1961). Patients whose disease was classified as
bacteriologically relapsed or active continued on the
chemotherapy prescribed for their first year of
treatment.
After excluding 26 patients for reasons given in
the earlier report (Tuberculosis Chemotherapy
Centre, 1960) there remained 315 patients (90 PH,
70 HI-1, 68 HI-2 and 87 H) who fulfilled the follow-
ing criteria: they were aged 12 years or more; they
had sputum positive for tubercle bacilli on culture
examination with organisms sensitive to isoniazid;
and they had not previously received more than two
weeks of antituberculosis chemotherapy (96.5 % of
the 315 patients had received none).
The isoniazid inactivation rates were not available
for 14 of these 315 patients: in two patients the tests
were contaminated; in one patient the blood was
AND OTHERS
collected half an hour too late; 11 patients (3 PH,
1 HI-1, 2 HI-2 and 5 H) had died before the earliest
month selected for the test. Of the 11 patients who
died, five did so from non-tuberculous causes and
six from tuberculosis, two of the latter during
the first month of treatment. In addition, two
patients (one slow and one rapid inactivator) were
excluded from the analysis as they had their treat-
ment changed in the second month because of hyper-
sensitivity to PAS. There remained 299 patients in
this analysis–namely, 83 (92%) of the 90 PH,
68 (97%) of the 70 HI-1, 66 (97%) of the 68 HI-2
and 82 (94%) of the 87 H patients.
The clinical, radiographic and bacteriological  
methods used in this investigation have been
described in detail elsewhere (Tuberculosis Chemo-
therapy Centre, 1960; Gangadharam et al., 1961 1).
A brief description of the methods used is, however,
given below.
Radiographic assessments
Radiographic assessments of the severity of the
disease on admission to treatment and of the changes
between 0 and 6 and between 0 and 12 months were
made from full-plate postero-anterior radiographs
by an independent assessor (Dr Raj Narain) who was
unaware of the treatment regimen to which any
patient had been allocated. The assessments of the
severity of the disease on admission to treatment
were: the extent of cavitation, graded as extensive,
modera e, slight or nil; the extent of the radiographic
lesions, classified as gross, extensive, moderate,
limited, slight or trivial; and the number of lung
zon s involved in disease, the presence of disease in
each zone being recorded no matter how limited in
extent. For the radiographic changes between 0 and
6 a d between 0 and 12 months, four grades of im-
provement were used-namely, exceptional, con-
siderable, moderate and slight-and three of de-
terioration-namely, slight, moderate and consider-
able.
Bacterial content of the sputum
Before the start of the treatment a minimum of
two overnight (collection) and two clinic (spot)
specimens of sputum were obtained. At the end of
every month of treatment two collection specimens,
of sputum and, from the third month onwards, in
addition, a pair of laryngeal swabs were obtained
from each patient. Sputum specimens were examined
1 See article on page 765.
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by fluorescence microscopy (Holst, Mitchison &
Radhakrishna, 1959) and were cultured, after treat-
ment with 4% NaOH, on Löwenstein-Jensen
medium which did not contain potato starch
(Jensen, 1955). Laryngeal swabs were cultured on
the same medium (Tuberculosis Chemotherapy
Centre, 1959).
Virulence in the guinea-pig
Pretreatment cultures from 266 of the 299 patients
were tested for virulence in the guinea-pig. The
degree of virulence was expressed as the root-index
   of virulence (Mitchison et al., 1961).
Rate of inactivation of isoniazid
The rate of inactivation of isoniazid was deter-
mined from the concentration of isoniazid in the
serum four-and-a-half hours after an intramuscular
injection of 3 mg/kg body-weight isoniazid. This
concentration was measured by microbiological
assay and patients with serum concentrations of
0.58 µg/ml or more were classified as slow inacti-
vators and those with serum concentrations below
0.58 µg/ml as rapid inactivators (Gangadharam et al.,
1961 1). The rate of inactivation of isoniazid was
determined between the sixth and the twelfth month
of treatment.
RESULTS
Number of slow and rapid inactivators
Of the 299 patients, 178 (60%) were slow inacti-
vators of isoniazid and 121 (40%) were rapid inacti-
   vators. Although there were differences between the
proportions of slow inactivators in the four treat-
ment series–69 % in the PH, 53 % in the HI-1,
59% in the HI-2 and 56% in the H series-none of
these differences was unusually large.
The results of this investigation are presented in
two sections. The first examines whether the condi-
tion of the slow and rapid inactivators on admission
to treatment was similar and the second whether
there was any difference between the response to
treatment of the slow and the rapid inactivators.
Condition on admission to treatment of slow and rapid
inactivators of isoniazid
Age and sex. The age-distributions of the slow
and the rapid inactivators were closely similar. Thus,
26 % of the slow and 33 % of the rapid inactivators
1 
See article on page 765.
were under 25 years of age and 15 % of each group
were ged 45 years or more.
Of the 178 slow inactivators 70% were males, as
compared with 55% of the 121 rapid inactivators.
This difference, which attains statistical significance
(P<0.01) and has been discussed elsewhere (Ganga-
dharam et al., 1961 1), is not, however, of importance
as there was no evidence from this study that response
to treatment was related to the sex of the patients.
Disease condition on admission to treatment.
Table 1 presents, separately for the slow and for the
rapid inactivators, three radiographic and two
bacteriological assessments of the disease at the start
of treatment. The distributions for the two groups
were very similar. For example, the majority of both
groups–namely, 63 % of the slow and 62 % of the
rapid inactivators had moderate or extensive cavita-
tion, the proportion with extensive cavitation being
10% and 12 %, respectively. In 62% of the slow
and 64% of the rapid inactivators the total extent of
disease was classified as limited or moderate; 28 %
and 30 %, respectively, had extensive or gross disease.
Considering the bacterial content of the sputum,
19 % of the slow and 15 % of the rapid inactivators
had a negative result on smear examination and
37% and 36%, respectively, had a 3-plus (heavy)
positive result. In 32 % of the slow and 34 % of the
rapid inactivators, the pretreatment cultures were of
low virulence in the guinea-pig and in 23 % of the
slow and 25 % of the rapid inactivators they were of
high virulence. The mean root-index of virulence for
the slow inactivators was 0.72 and for the rapid
inactivators 0.74.
Further analyses (not tabulated here) were under-
taken separately for each of the four treatment series
to see whether the distributions of slow and rapid
inactivators within each treatment series differed in
any of the above five factors. In the main the
distributions were similar, but there were some
differences which were as follows: In the PH series,
59 % of the slow inactivators, as compared with 74 %
of the rapid inactivators, had moderate or extensive
cavitation. In the HI-2 series, the slow inactivators
were at an advantage in that 18% had extensive or
gross disease, as compared with 30% of the rapid
inactivators,and in respect of the guinea-pig
virulence of their pretreatment cultures, the mean
root-index of virulence being 0.61 for the slow
inactivators and 0.73 for the rapid inactivators
(P = 0.02). On the other hand, they were at a
disadvantage in respect of the important prognostic
factor, cavitation (Tuberculosis Chemotherapy Cen-
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TABLE 1
CONDITION ON ADMISSION TO TREATMENT
OF SLOW AND RAPID INACTIVATORS OF ISONIAZID
Assessment
on admission to treatment
Slow Rapid
inactivators inactivators
No. % No. %
- -
Extent of cavitation :
Nil
Slight
Moderate
Extensive
15 8 7 6
51 2 9 39 3 2
94 5 3 61 5 0
18 1 0 14 1 2
Total extent of disease :
Trivial or slight
Limited or moderate
Extensive or gross
18 1 0 8 7
110 6 2 77 6 4
50 2 8 36 3 0
Number of lung zones involved
in disease:
1 or 2
3 or 4
5 or 6
Bacterial content of sputum:
Direct smear {Culture negativenegative Culture positive
35 2 0 25 2 1
77 4 3 44 3 6
66 3 7 52 4 3
7 4 2 2
25 1 4 16 1 3
34 1 9 16 1 3
47 2 6 43 3 6
65 3 7 44 3 6
Total 178 1 0 0 121 100
Root-index of virulence:
0.0 -
0.6 -
0.9 or above
Total
50 3 2
69 4 5
36 23
155a 100
38 34
45 4 1
28 2 5
111 b 100
a Results for 23 patients not available.
b Results for 10 patients not available.
tre, 1960), 72 % having moderate or extensive cavita-
tion, as compared with 56 % of the rapid inactivators.
In the H series, 37 % of the slow inactivators had five
or six lung zones involved in disease, as compared
with 58% of the rapid inactivators, but on the other
hand, 47% of the slow inactivators had 3-plus
positive smears, as compared with 28% of the rapid
inactivators. With the exception of the difference
between the slow and the rapid inactivators in the
HI-2 series in respect of the virulence of their pre-
treatment cultures in the guinea-pig, none of these
differences attains statistical significance.
In summary, the slow and the rapid inactivators
were very similar in terms of the major pretreatment
disease factors when all 299 patients were considered.
When, however, the treatment series were examined
separately, there was a suggestion that the slow
inactivators were at an advantage in the PH series.
Comparison of response to treatment of slow and rapid
inactivators of isoniazid
Changes of treatment during the first 12 months.
Forty patients had their treatment changed during
the 12 months. Of these changes, 32 were made on
the recommendation of an independent assessor,
Dr K. S. Sanjivi, on account of serious radiographic
deterioration and two more were made on account
of severe clinical deterioration.The procedure
adopted for assessing radiographic deterioration that
warranted a change of treatment has been presented
in detail elsewhere (Tuberculosis Chemotherapy
Centre, 1960). Since all these 34 patients yielded
positive results, both on smear and on culture, at the
time treatment was changed and since all had yielded
three or more cultures which were resistant to
isoniazid, they have been regarded as smear-and 
culture-positive for the remainder of the 12 months
in the bacteriological analysis (see page 784).
The remaining six patients (all slow inactivators;
5 HI-1, 1 HI-2) had their treatment changed because
of peripheral neuritis. Of these, four were positive
on smear examination and five were positive on
culture at the time of changing treatment (one in the
fifth month, two in the sixth month, one in the tenth
month and one in the eleventh month), and all of
them had yielded two or more isoniazid-resistant
cultures.Since most of the patients in this study who
were still culture-positive at five months or later, and
nearly all (86%) who yielded two or more cultures
resistant to isoniazid during the first 12 months,
failed to convert to bacteriological negativity during
this period, these five patients have been regarded
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as positive on smear and culture for the remainder
of the 12 months. The sixth patient (HI-1) had
treatment changed on account of peripheral neuritis
in the seventh month, after having been culture-
negative at three, four, five and six months. He has
therefore been classified as bacteriologically quiescent
at 12 months. While there may be an element of
error involved in the above classification of the
response of these six patients, it must be pointed out
that their exclusion would have been a serious source
of bias, because these six patients cannot be con-
sidered to be a random sample of the slow inactiva-
tors. Thus, whereas five of the six patients yielded
two or more isoniazid-resistant cultures-a bad
  prognostic factor–only 20 (30%) of the remaining
69 slow inactivators in the HI-1 and HI-2 series did
so, a significant difference (P = 0.02).
Radiographic response. The change in radiogra-
phic appearances of slow and rapid inactivators of
isoniazid between 0 and 6 months is shown in
Table 2. During the first six months of treatment,
three slow inactivators (2 HI-1, 1 HI-2) had their
treatment changed because of peripheral neuritis.
Two of these (1 HI-1, 1 HI-2) had their treatment
ch g d after they had completed five months of
treatment. These two patients have been included
in Table 2 since it is unlikely that the radiographic
appearances would have changed much during the
sixth month. The proportion of slow and rapid
inactivators who showed moderate or greater im-
provement at six months were 79% and 81%,
respectively, in the PH series, 78% and 66 % in the
HI-1 series, 62% and 67% in the HI-2 series and
67% and 78 % in the H series. On amalgamating
th four series, the proportions were 72 % and 73 %,
respectively. There was thus no difference between
th  rapid and the slow inactivators in this respect.
The proportions of slow and rapid inactivators who
showed radiographic deterioration were 0% and
4%, respectively, in the PH series, 0% and 15 % in
the HI-1 series, 3 % and 11% in the HI-2 series and
9 % and 14 % in the H series. On amalgamating the
four series, the proportions were 3% and 11%,
respectively. In both the HI-1 and the amalgamated
series the differences attain significance (P = 0.02
and P < 0.01, respectively). There was thus a clear
difference between the proportions of slow and
rapid inactivators who had deteriorated radio-
graphically by six months.
TABLE 2
RADIOGRAPHIC RESPONSE IN THE FIRST SIX MONTHS IN SLOW AND RAPID INACTIVATORS OF ISONIAZID
Radiographic response Change of chemotherapy due to:
Treatment Rate of inacti- Total patients
series vation of Deterioration Deterioration
Peripheral
isoniazid neuritis
a Including one patient whose treatment was changed in the sixth month because of peripheral neuritis.
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The analysis of the radiographic changes between
0 and 12 months (not tabulated here) was com-
plicated by the fact that eight patients had had their
treatment changed during the 12 months for reasons
other than radiographic deterioration, six because of
peripheral neuritis and two on account of severe
clinical deterioration. An attempt was made to
predict the probable radiographic progress of these
eight patients between 0 and 12 months from their
bacteriological and radiographic results up to the
time they had their treatment changed. Bearing in
mind that this may be inaccurate, the analysis of the
0 to l2-month radiographic changes yielded similar
results to those obtained at six months, but the
difference between the proportions of slow and rapid
inactivators who had deteriorated was smaller.
Bacteriological response. The bacteriological res-
ponse to treatment of the slow and the rapid in-
activators of isoniazid was studied by comparing, at
each month of treatment, the proportions of slow
and rapid inactivators whose two collection speci-
mens of sputum were negative on culture (see
accompanying figure).All the 34 patients whose
treatment was changed because of clinical or radio-
graphic deterioration and five of the six patients
whose treatment was changed because of peripheral
neuritis have been regarded as culture-positive for
the remainder of the 12 months after they changed
treatment. The reasons for adopting this procedure
are given on pages 782 and 783.
PERCENTAGE OF SLOW AND RAPID INACTIVATORS
EACH MONTH WHOSE COLLECTION SPECIMENS
OF SPUTUM WERE NEGATIVE ON CULTURE
In all the four treatment series, the proportion of
patients whose sputum became culture-negative was
larger in the slow than in the rapid inactivators. This
difference became apparent at five months in the PH
series, at four months in the HI-1 series, at two
months in the HI-2 series, and at five months in the
H series. The magnitude of the difference between
the slow and the rapid inactivators remained fairly
constant during the rest of the year in the HI-1 and
HI-2 series, but became smaller at 11 and 12 months
in the PH series, and extremely small between nine
and 12 months in the H series. On amalgamating
the four treatment series, the difference between the
proportions for the slow and the rapid inactivators
was 16% at five months, 15% at six and at seven
months, 12 % at eight months, 18 % at nine months,
10% at 10 and at 11 months, and 11% at 12 months.
The differences at five, six, seven, eight and nine
months attain statistical significance.
Table 3 presents the month of bacteriological con-
version (first of three or more consecutive months
during which all the specimens were negative on
culture) for the slow and the rapid inactivators who
achieved bacteriological quiescence by 12 months.
In all four series the majority of slow and rapid
inactivators who converted did so within the first
three months of treatment. Amalgamating the four
series, 75 % of the 119 slow inactivators converted
bacteriologically in the first three months, 21% in
the second three months and 4 % between seven and
10 months. The corresponding proportions for the
70 rapid inactivators were 67 %, 23 % and 10%,
respectively. None of these differences attains
significance (P> 0.1). Thus, there was only a slight
suggestion that the slow inactivators converted
bacteriologically earlier than the rapidin ctiva-
tors.
Analyses (not tabulated here) failed to demonstrate
differences between the slow and the rapid inacti-
vators in the degree of positivity, as assessed by
smear examination, of the sputum specimens that
were culture-positive at six, nine or 12 months.
In summary, there was a suggestion that the slow
inactivators of isoniazid more frequently became
negative on culture during treatment than the rapid
inactivators.There was slight evidence of a difference
between the slow and the rapid inactivators in the
speed of conversion to bacteriological negativity
among those patients who achieved quiescence by
12 months but not in the degree of positivity of the
sputum specimens that were culture-positive at six,
nine or 12 months.
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TABLE 3
MONTH OF CONVERSION TO BACTERIOLOGICAL NEGATIVITY OF SLOW AND RAPID INACTIVATORS OF
ISONIAZID
PH
Slow 24 100 18 (75) 5
HI-1                  
(21) 1 (4)
Rapid
I
18 101 14 (78) 3 (17) 1 (6)
Slow 22 101 18 (82) 3 (14) 1 (5)
HI-2
Rapid 15 100 9 (60) 4 (27) 2 (13)
Slow 22 100 15 (68) 5 (23) 2 (9)
H
Rapid 16 100 12 (75) 1 (6) 3 (19)
All series
Slow 119 100 89 75 25 21 5 4
Rapid 70 100 47 67 16 23 7 10
a First of three or more consecutive months during which all specimens were negative on culture.
b The parentheses indicate percentages based on fewer than 25 observations.
Classification of patients according to their response
to treatment during the 12 months. The disease in the
patients who completed 12 months of the prescribed
chemotherapy was classified bacteriologically as
“ quiescent ” if all the sputum specimens and laryn-
geal swabs examined during the last three months
(that is, at 10, 11 and 12 months) were negative on
      culture; as of “ doubtful status ” if, following at least
three consecutive months of culture negativity, the
patient yielded an isolated positive culture during
the last three months; as “ relapsed ” if, following at
least three consecutive months of culture-negativity,
two or more positive cultures were obtained during
the last three months; and as “ active ” if the patient
had never had a period of three consecutive months
during which all the cultures were negative.
Table 4 presents the status of the slow and the
rapid inactivators at 12 months according to the
above classification of their response to treatment.
In this table the nine patients (4 PH, 4 HI-1, 1 HI-2)
whose disease was classified as of doubtful status have
been amalgamated with the quiescent group. This
procedure was adopted since they were relatively few
in number and their subsequent progress was similar
to that of the patients with quiescent disease (Velu
et al., 1961). In addition to the patients who com-
pleted 12 months of the prescribed chemotherapy
there were 34 patients who had had their chemo-
therapy changed because of clinical or radiographic
eterioration and six who had had their chemo-
therapy changed on account of peripheral neuritis.
In the calculation of the percentages quoted below,
five of the six patients whose treatment was changed
becaus  of peripheral neuritis have been regarded as
having active disease at 12 months, and the sixth
(HI-1) s having quiescent disease (see page 782).
In all four treatment series, the proportion of slow
inact vators whose disease was bacteriologically
quiescent or of doubtful status was larger than that
of the rapid inactivators, the figures being 95 % and
85 %, respectively, in the PH series,1 72 % and 66 %,
respectively, in the HI-1 series, 59 % and 56%,
respectively, in the HI-2 series and 48 % and 44 %,
resp ctively, in the H series. Amalgamating the four
treatment series, 125 (70%) of the slow inactivators
as compared with 74 (61%) of the rapid inactivators
1 Wh n standardization was undertaken for the pretreat-
ment differences in the extent of cavitation on admission to
treatment (see page 781), these proportions were 95% and
87 %, respectively.
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TABLE 4
BACTERIOLOGICAL STATUS AT 12 MONTHS OF SLOW AND RAPID INACTIVATORS OF ISONIAZID
Bacteriological status at 12 months Change of chemotherapy due to:
Treatment Rate of inacti- Total patients Quiescent or Peripheral
series vation of Deterioration
isoniazid
neuritis
a Five of these patients (4 HI-1, 1 HI-2) were classified as having bacteriologically active disease at 12 months and one (HI-1) as
having quiescent disease.
had quiescent disease. None of these differences,
however, attains significance, though that for the
amalgamated series only just fails to do so (P=O.O7).
Change of treatment due to deterioration occurred
in 0% of the slow and 4% of the rapid inactivators
in the PH series, 0% and 16% in the HI-1 series,
21% and 22 % in the HI-2 series and 9 % and 28 %
in the H series, respectively. On amalgamating the
four treatment series, the proportions were 7%
and 18 %, respectively. The difference between the
proportions of slow and rapid inactivators who
deteriorated to an extent that warranted a change
of treatment attains significance in the H series
(P ~ 0.05) and in the amalgamated series (P<0.01).
It must be pointed out that five of the six slow
inactivators whose treatment was changed because
of peripheral neuritis have been classified as bacterio-
logically active but not as deteriorated at 12 months.
However, if these five patients are classified as having
deteriorated to an extent that warranted a change of
treatment, the difference between the slow and rapid
inactivators in the amalgamated series still attains
significance (P=0.05). This association is discussed
further on page 787.
Response during the second year. Of the 198
patients (124 slow and 74 rapid inactivators) whose
disease was classified bacteriologically as quiescent
or of doubtful status at the end of the first 12 months,
186 (115 slow and 71 rapid inactivators) were allo-
cated at random to treatment with either calcium
gluc nate 0.5 g daily or isoniazid in a dosage of
approximately 4.5 mg/kg body-weight daily for a
further 12 months. Of the 12 patients not allocated
o treatment at random, six were misclassified at
12 months as having bacteriologically active disease
and continued on their original chemotherapy, five
were regarded as being unlikely to co-operate for a  
further year and were therefore given calcium gluco-
nate and one was, in error, kept on his original
treatment until 15 months before being changed to
calcium gluconate.
There were no major differences between the
p ti nts randomly allocated to treatment with iso-
niazid or calcium, or between the slow and the rapid
inact vators in each treatment series, in respect of
t e severity of the disease at the end of the first
12 months. In Table 5, the response during the
second year of the slow and the rapid inactivators
who were randomly allocated to treatment is related
to the presence of cavitation at 12 months and to the
second-year regimen. The disease in all the 59 slow
inactivators who received isoniazid remained bacte-
RATE OF INACTIVATION OF ISONIAZID IN TUBERCULOUS PATIENTS IN INDIA. 2 787
TABLE 5
RESPONSE TO TREATMENT IN THE SECOND YEAR OF SLOW AND RAPID INACTIVATORS
WHO HAD BACTERIOLOGICALLY QUIESCENT DISEASE OR DISEASE OF DOUBTFUL STATUS AT 12 MONTHS
Rate of inactivation of isoniazid
Total
patients
Slow Rapid
Quiescent a Quiescent a
Number throughout the Number throughout the
of patients second year of patients second year
No. % No. %
Isoniazid
Cavitated
a Not more than one positive culture in any B-month period.
b The parentheses indicate percentages based on fewer than 25 observations.
c Excluding one patient who died from a non-tuberculous cause in the 22nd month.
riologically quiescent (not more than one positive
culture in any 6-month period) during the second
year, as compared with 33 (94%) of the 35 rapid
inactivators on isoniazid and 50 (91%) of the 55 slow
inactivators and 32 (89%) of the 36 rapid inactivators
on calcium gluconate. There was thus evidence
that the slow inactivators who received isoniazid
fared more favourably than the other patients.
Of the patients who continued on their initially
prescribed chemotherapy for the whole of the first
year, the disease in 16 was classified bacteriologically
as relapsed and in 45 as active at 12 months. Of
these 61 patients, 57 (33 slow, 24 rapid) continued
on their initially prescribed treatment in the second
year (Ramakrishnan et al., 1962). (Three patients
(slow inactivators) did not continue on their initially
prescribed chemotherapy because they were mis-
classified at 12 months as bacteriologically quiescent
and consequently allocated at random to treatment
with calcium gluconate or isoniazid for the second
year, and one rapid inactivator had his treatment
changed in the thirteenth month because of severe
cor pulmonale.The one patient who was allocated to
isoniazid had bacteriologically quiescent disease
throughout the second year and the two who re-
ceived calcium gluconate had bacteriologically active
disease at 24 months. The patient with cor pulmonale
died in the fifteenth month.) At the end of the
second year, 15 % of the 33 slow inactivators had
bacteriologically quiescent disease, as compared
with 17 % of the 24 rapid inactivators; 15 % of the
slow inactivators had active disease, as compared
with 42 % of the rapid inactivators, and 70% had
deter orated to an extent that warranted a change of
treatment, as compared with 42% of the rapid
inactivators. This difference between the proportions
of the slow and the rapid inactivators who deterio-
rated in the second year does not attain significance.
It should, however, be noted that it is in the opposite
direction to that observed in the first year; this is
discussed further below.
Occurrence during the two years of deterioration
that warranted a change of treatment. Deterioration
that was sufficiently serious to warrant a change of
treatment occurred during the two years in 35 (20 %)
of the 178 slow inactivators and 32 (27 %) of the
120 rapid inactivators whilst they were receiving
their initially prescribed chemotherapy. The month
at which the deteriorations occurred is given in
Table 6. (These figures do not include one rapid
inactivator (H series) who had bacteriologically
active disease at 12 months and had his treatment
changed in the thirteenth month because of cor
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TABLE 6
MONTH IN WHICH SERIOUS RADIOGRAPHIC OR CLINICAL DETERIORATION OCCURRED DURING THE TWO YEARS
IN SLOW AND RAPID INACTIVATORS OF ISONIAZID
Treatment series
HI-1 HI-2PH H All series
Month of treat-
ment change
0- 4
5- 8
9-12
13-16
17-20
21-24
Total
Slow
inactivators
No. %
Slow in- Rapid in-
ctivators activators
3
Slow in- Rapid in-
ctivators activators
Slow in- Rapid in-
activators activators
0 0 0
3 2 4
3 2 6
1 7 1
0 6 2
1 3 0
8
Slow in-
activator
R
s ac
apid in-
tivators
0 0
5 14
7 2 0
7 2 0
11 3 1
5 14
0 0
9 28
13 4 1
2 6
4 8 35 99 32 1 0 020 13
pulmonale but without evidence of radiographic
deterioration, and one slow and one rapid inactivator
whose disease relapsed bacteriologically with a
radiographic deterioration in the second year, after
having had their treatment changed to calcium
gluconate at 12 months because they had bacteriolo-
gically quiescent disease.) Except for two patients
who had their treatment changed in the first year on
account of severe clinical deterioration, all these
patients had their treatment changed on the re-
commendation of an independent assessor because of
serious radiographic deterioration. All the patients
had culture-positive results, with organisms resistant
to isoniazid, at the time they changed treatment.
Considering the PH series, the one slow inactivator
who deteriorated and had his treatment changed
did so in the second year, whereas one of three rapid
inactivators did so in the first year. Considering the
HI-1 series, none of four slow inactivators, as
compared with five of eight rapid inactivators, who
deteriorated and had their treatment changed did so
in the first 12 months (P = 0.07).The correspond-
ing proportions for the HI-2 series were eight of
10 and six of eight, respectively, and for the H series,
four of 20 and 10 of 13, respectively (P ~ 0.01).
Amalgamating the four treatment series, 34 % of the
35 slow inactivators who deteriorated and had their
treatment changed did so in the first 12 months,
as compared with 69% of the 32 rapid inactivators
(P ~ 0.02). This association in the HI-1 and H
series between the rate of inactivation and the
month in which deterioration that warranted a
change of treatment occurred explains why at
12 months but not at 24 months there was a signifi-
cant difference between the proportions of slow and
r pid inactivators who had deteriorated to this
ex nt.
Resp se to treatment of slow and rapid inactivators
of isoniazid related to severity of disease on admission
to treatment.Table 7 presents the response to
treatment at 12 months of the slow and rapid inac-
tivator  of isoniazid related to three pretreatment
as essments of the severity of disease that have been
show  to be of prognostic value (Tuberculosis
Chem therapy Centre, 1960). These assessments
were: the extent of cavitation; the degree of sputum
positivity, as assessed by smear examination; and
the virulence in the guinea-pig of pretreatment
cultures of tubercle bacilli. (As there was little
difference between the four treatment series, only
the amalgamated figures are presented in Table 7.)
Considering the extent of cavitation, the difference
between the proportions of slow and rapid inactiva-
tors with slight or no cavitation who had bacterio-
logically quiescent disease at 12 months was 9 % and
that for patients with moderate or extensive cavita-
tion was also 9%. The difference for patients with
smear-negative results was 3 % and for those with
smear-positive results 9%. For patients with pre-
treatment cultures of low virulence (root-index of
virulence of 0-0.59) the difference was 2% and for
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TABLE 7
RESPONSE TO TREATMENT AT 12 MONTHS OF SLOW AND RAPID INACTIVATORS OF ISONIAZID RELATED TO
SEVERITY OF DISEASE ON ADMISSION TO TREATMENT
Assessment on admission to treatment
Sputum positivity
I
Virulencein the guinea-pig (root-index
of virulence)
Smear-negative Smear-positive
Favour- Favour-
Total able res- Total able res-
patients ponse a
No. %  
patients ponse a
 No .  %
32 31 97 146 94 64
18  17 ( 9 4 )b 103  57 5 5
 
0-0.59 0.60 or above
Favour-
Total able res-
patients ponse a
No.  %
 Favour-
Total able res-
patients ponse a
No. %
50 34 6 8 105 75 7 1
I
38 25 6 6 73 42 5 8
a Bacteriologically quiescent disease or disease of doubtful status at 12 months. 
b This percentage is based on fewer than 25 observations.
patients with cultures of moderate or high virulence
(root-index of virulence of 0.60 or above) 13 %. The
only difference in response which attains signifi-
cance was that for the patients with smear-positive
results (0.01 < P <0.05). There was thus a slight
suggestion that the influence of the rate of inactiva-
tion of isoniazid on the response to treatment was
greatest in patients who (a) had smear-positive
specimens on admission to treatment and (b) were
infected with tubercle bacilli of moderate or high
virulence in the guinea-pig. There was, however,
no evidence that the extent of cavitation on admis-
sion to treatment influenced the association between
the rate of inactivation and the response to treat-
ment.
Response to treatment related to the degree of
rapid inactivation f isoniazid. Price Evans, Manley
& McKusick (1960) have shown that homozygous
rapid inactivators inactivate isoniazid more rapidly
than heterozygous rapid inactivators. Analyses
(not tabulated here) were therefore undertaken to
compare the response to treatment of the 12 rapid
inactivators who had very low serum concentrations
of isoniazid (less than 0.2 µg/ml) four-and-a-half
hours after the test dose of 3 mg/kg body-weight
isoniazid with the remaining 109 rapid inactivators.
There was no clear indication from these analyses
that these 12 patients responded less favourably to
treatment than the remaining rapid inactivators.
It must be pointed out, however, that the numbers
considered in this analysis were very small and that
the genotype of the patients had not been deter-
mined.
DISCUSSION
Since Hughes, Schmidt & Biehl (1955) demon-
strated that patients vary widely in their rate of
inactivation of isoniazid, a number of investigations
have been undertaken to determine whether these
differences are associated with differences in response
to treatment with isoniazid. Indirect evidence which
suggests that such a relationship does exist is avail-
able from a study reported by Mandel et al. (1957)
and more direct evidence has been presented by
Mitchell & Bell (1957). Mandel et al. (1957) found,
in a study on 56 patients in whom isoniazid-resistant
cultures emerged during treatment, that catalase-
negative strains occurred significantly more fre-
quently amongst slow than amongst rapid inactiva-
tors. Cohn et al. (1954) had reported that catalase-
negative isoniazid-resistant strains of tubercIe
bacilli were less virulent in the guinea-pig than
catalase-positive isoniazid-resistant strains. Since
this relationship between the catalase activity of
ub rcle bacilli and their virulence may also apply in
man (Oestreicher et al., 1955), Mandel et al. (1957)
suggested that slow inactivators could be expected to
respond to treatment better than rapid inactivators.
Mitchell & Bell (1957) studied 44 patients and related
the f equency of sputum conversion to bacterio-
logical negativity by the sixth month of treatment to
the rate of inactivation of isoniazid. All the patients
had received 12 mg/kg body-weight isoniazid daily,
and in addition either PAS or streptomycin or both.
At six months, specimens from 20 of the 22 slow
inactivators were negative on culture, as compared
with 14 of the 22 rapid inactivators. This study was
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subsequently extended to include 123 patients, who
were divided into four groups on the basis of the
severity of the disease on admission to treatment and
the chemotherapeutic regimens they received (Mit-
chell et al., 1958). In two of the four groups, the
slow inactivators fared more favourably than the
rapid inactivators in respect of the frequency of
sputum conversion by six months, but in neither
were the differences statistically significant. Also, the
patients studied were a selected group, being the only
patients, among a much larger number originally
admitted to treatment, who received uninterrupted
treatment with isoniazid for this period. Further,
it was not reported whether the radiographic and
bacteriological conditions of the slow and rapid
inactivators at the start of treatment were similar.
On the other hand, two other studies have failed
to demonstrate a relationship between response to
treatment and the rate of inactivation of isoniazid
(Biehl, 1957; Barclay, 1959). Biehl(1957) determined
the rate of inactivation of isoniazid by the percentage
of the daily dose of isoniazid excreted as free iso-
niazid in the urine in 24 hours and related this to the
frequency of the emergence of isoniazid-resistant
strains. The data from this investigation have been
subjected to statistical analysis by Price Evans,
Manley & McKusick (1960) and no significant
association was found. Barclay (1959) stated that
no relationship was observed in a study on 125
patients, but did not present the details of the
investigation referred to.
The 299 patients considered in the present report
were drawn from the 315 patients who were included
in the main analysis of the chemotherapy study
(Tuberculosis Chemotherapy Centre, 1960). On
admission they had not received more than two
weeks of previous antituberculosis chemotherapy
(96.5% had received none) and all yielded cultures
of tubercle bacilli which were sensitive to isoniazid.
They were allocated at random to treatment for
12 months either with isoniazid plus PAS (PH regi-
men) or with isoniazid alone, either in a daily dosage,
on the average, of 8.7 mg/kg given in one dose a day
(HI-1 regimen) or in two doses a day (HI-2 regimen)
or in a daily dosage, on the average, of 4.5 mg/kg
given in two doses a day (H regimen). At the end of
12 months patients who had disease which was
bacteriologically quiescent or of doubtful status
were allocated at random to treatment for a further
12 months with 0.5 g of calcium gluconate daily or
with isoniazid in a dosage of about 4.5 mg/kg daily.
Patients who had disease which was bacteriologically
active or relapsed, but which had not deteriorated to
an extent which warranted a change of treatment,
continued on their initially prescribed chemotherapy
for a second year. Of the 299 patients, 178 were
classified as slow inactivators and 121 as rapid
inactivators. The 178 slow and 121 rapid inactivators
were very similar in terms of the major assessments
of t  condition of their disease on admission to
treatm nt. However, when the disease condition of
the slow and the rapid inactivators on admission to
treatment was compared separately in the four
treatm nt series, there was a suggestion that the
slow inactivators in the PH series were possibly
at an a vantage in respect of the extent of cavitation.
Since standardization for this pretreatment difference
did not substantially alter the difference between the
response to treatment of the slow and the rapid
inactivators, the unstandardized percentages have
been presented in this report. The results of this
study have been presented for the four treatment
series not only separately, but amalgamated also,
because the associations encountered were in the
same direction in all the series. Furthermore, the
magnitudes of the differences between the responses
of th  slow and the rapid inactivators were of the
same order.
Before considering the results, it is necessary to
consider a source of possible bias in the analysis.
Since the rate of inactivation was determined in the
second six months of treatment, results are not
available for the 11 patients who died before the
det rmination was carried out. However, only six
(1 PH, 1 HI-1, 4 H) of these 11 patients died from
tuberculosis and two of them (both H) did so within
the first month of treatment.
The results of the present investigation suggest
t at there probably was an association between
respon e to treatment and the rate of inactivation of
isoniazid. When the four treatment series were
amalgamated the slow inactivators appeared to
have responded more favourably to treatment than
the rapid inactivators, in that:
(a) They were more often culture-negative during
the first 12 months of treatment.
(b) A larger proportion of them had bacteriologi-
ally quiescent disease at 12 months (P = 0.07).
(c) A smaller proportion of them showed radio-
graphic deterioration at six months (P<0.01).
(d) those who deteriorated radiographically or
clinically to an extent warranting a change of treat-
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ment during the two years did so later than the rapid
inactivators (P< 0.02).
There was slight evidence that the slow and the
rapid inactivators differed in respect of the speed of
conversion to bacteriological negativity of those
patients who had bacteriologically quiescent disease
at 12 months, but no evidence that they differed in the
degree of positivity of sputum specimens which were
positive on culture at six, nine or 12 months or in the
frequency with which they showed moderate or
greater radiographic improvement at six months.
There was evidence amongst the patients with
bacteriologically quiescent disease or disease of
doubtful status at 12 months, and who received
random isoniazid or calcium gluconate in the
second year, that the slow inactivators who received
isoniazid relapsed bacteriologically less frequently
than the other patients.
It must be emphasized that the association sug-
gested by this investigation between the rate of
inactivation of isoniazid and the response to treat-
ment was weak and that rapid inactivation could
only have been responsible for the failure of chemo-
therapy in a small proportion, estimated to be
approximately 4%, of the patients admitted to this
study. Furthermore, the association has only been
demonstrated in the amalgamated results of the four
treatment series; in consequence, it cannot be said
that it will necessarily hold true for each one of the
regimens separately.
The rate of inactivation of isoniazid is genetically
determined, slow inactivation being due to the
presence of two recessive alleles (Knight, Selin St
Harris, 1959; Price Evans, Manley & McKusick,
1960). As there were no major differences between
the proportions of slow inactivators among healthy
subjects and among patients with pulmonary tuber-
culosis in the American population studied by Price
Evans, Manley & McKusick (1960), it seems reason-
able to regard the preponderance of slow inactivators
among the patients in this study as reflecting a
preponderance of this genotype in the general South
Indian population. Since the predominance of a
recessive genotype in a population suggests that such
a genotype confers a biological advantage, it could
be argued that the slow inactivators responded more
favourably to treatment than the rapid inactivators
not because they inactivated isoniazid more slowly
but because of this associated biological advantage.
However, this seems unlikely, for there was little
diffe ence between the slow and the rapid inactivators
in the severity of their disease on admission to
treatm nt and the relapse rates for the slow and the
rapid inactivators who received calcium gluconate
in the second year were similar.
SUMMARY
1. The rate of inactivation of isoniazid was
determined in 299 of 315 patients in the main analysis
of a controlled study of three regimens of isoniazid
alone and one of isoniazid plus PAS in the domi-
ciliary treatment of pulmonary tuberculosis. The
patients were aged 12 years or more and all had
yield d, on admission to treatment, cultures of
tub rcle bacilli which were sensitive to isoniazid.
2. The slow and the rapid inactivators were very
similar in terms of the major assessments of the
condition of their disease on admission to treatment
when all 299 patients were considered. There were,
however, minor differences between the slow and
the rapid inactivators when the four treatment series
were examined separately.
3. The differences between the response to treat-
ment of the slow and the rapid inactivators in the
four treatment series were fairly similar.
4. There was a suggestion that the slow inactiva-
tors responded slightly more favourably to treatment
than the rapid inactivators, in four respects:
(a) They were more often culture-negative during
treatment.
(b) A larger proportion of them had bacteriolo-
gically quiescent disease at 12 months.
(c) A smaller proportion of them showed radio-
graphic deterioration at six months.
(d) Those who deteriorated radiographically or
clinically to an extent warranting a change of
treatment during the two years did so later than
the rapid inactivators.
5. There was slight evidence that the slow and the
rapid inactivators differed in the speed of conversion
o bacteriological negativity of those patients who
had bacteriologically quiescent disease at 12 months,
but n  difference between them in the degree of
positivity of sputum specimens which were positive
on culture at six, nine or 12 months or in the fre-
quency with which they showed moderate or greater
rad ographic improvement at six months.
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